{
  "meta": {
    "title": "25_Cirrhosis_And_Complications",
    "url": "https://brainandscalpel.vercel.app/25-cirrhosis-and-complications-e47b135a.html",
    "scrapedAt": "2025-11-30T12:28:32.363Z"
  },
  "questions": [
    {
      "text": "Which of the following conditions is unlikely to lead to cirrhosis in a patient?",
      "choices": [
        {
          "id": 1,
          "text": "Alpha 1 antitrypsin deficiency"
        },
        {
          "id": 2,
          "text": "Cystic fibrosis"
        },
        {
          "id": 3,
          "text": "Nonalcoholic steatohepatitis"
        },
        {
          "id": 4,
          "text": "Hepatitis A"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Hepatitis A</strong> infection is an <strong>acute self-limiting</strong> condition that does not lead to cirrhosis.</p>\n<p><strong>Cirrhosis</strong> is a late stage of <strong>chronic liver disease</strong> pathologically characterized by hepatic fibrosis, distortion of hepatic architecture, and formation of regenerative nodules.&nbsp;</p>\n<p>The <strong>causes of cirrhosis</strong> are:</p>\n<ul>\n<li>Chronic viral hepatitis -&nbsp;Hepatitis B and C&nbsp;</li>\n<li>Alcoholic liver disease</li>\n<li><strong>Nonalcoholic fatty liver disease</strong></li>\n<li>Autoimmune hepatitis</li>\n<li>Biliary cirrhosis -\n<ul>\n<li>Primary biliary cholangitis</li>\n<li>Primary sclerosing cholangitis</li>\n</ul>\n</li>\n<li>Cardiac cirrhosis</li>\n<li>Inherited metabolic liver diseases -<br />\n<ul>\n<li><strong>Cystic fibrosis</strong></li>\n<li>Hemochromatosis</li>\n<li>Wilson's disease</li>\n<li><strong>&alpha;<sub>1&nbsp;</sub>Antitrypsin deficiency</strong></li>\n</ul>\n</li>\n<li>Cryptogenic cirrhosis</li>\n<li>Drugs - methotrexate, isoniazid</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1207",
      "difficulty": "easy"
    },
    {
      "text": "While examining a chronic alcoholic patient, you notice the given finding. Which of the following is false regarding it?",
      "choices": [
        {
          "id": 1,
          "text": "Occurs due to alterations in the metabolism of estrogen"
        },
        {
          "id": 2,
          "text": "Presence of even 1 lesion is abnormal"
        },
        {
          "id": 3,
          "text": "Commonly seen over the superior vena cava territory"
        },
        {
          "id": 4,
          "text": "Compression results in blanching followed by reappearance after release"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows&nbsp;<strong>spider telangiectasia</strong>&nbsp;and the presence of <strong>&gt;2 to 3</strong> of these are considered <strong>abnormal</strong>.</p>\n<p>Spider telangiectasias are dilated arterioles with a <strong>prominent central arteriole</strong> with <strong>radiating vessels</strong> appearing in the shape of a spider. They are generally seen in the <strong>superior vena cava territory</strong>.&nbsp;<strong>Compression</strong> results in <strong>blanching</strong> followed by <strong>reappearance after</strong> the <strong>release</strong> of pressure. They occur due to a <strong>hyperestrogenic state</strong> which is caused by defective estrogen metabolism in liver cirrhosis.</p>\n<p><strong>Clinical features</strong>&nbsp;seen in <strong>cirrhosis</strong>&nbsp;include:</p>\n<ul>\n<li>Spider telangiectasias</li>\n<li>Palmar erythema</li>\n<li>Terry's nails - pallor of the proximal nail bed</li>\n<li>Clubbing</li>\n<li>Gynaecomastia</li>\n<li>Caput medusae - dilated abdominal veins.</li>\n<li>Parotid enlargement</li>\n</ul>\n<p>The image below shows Terry's nails.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1439eb59bb694818b832990dac1e927cx800x1067.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/12149eea511347dba64938cc75f801dc.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1203",
      "difficulty": "medium"
    },
    {
      "text": "Clinically significant portal hypertension is defined as a hepatic venous pressure gradient greater than _____ mm Hg.",
      "choices": [
        {
          "id": 1,
          "text": "3"
        },
        {
          "id": 2,
          "text": "10"
        },
        {
          "id": 3,
          "text": "5"
        },
        {
          "id": 4,
          "text": "12"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Clinically-significant portal hypertension</strong> is defined as hepatic venous pressure gradient (<strong>HVPG</strong>)<strong> &ge;10 mm Hg.</strong></p>\n<p class=\"p1\">HVPG is the <strong>difference between</strong> the <strong>wedged</strong> hepatic venous pressure (WHVP) and the <strong>free hepatic venous&nbsp;pressure</strong> (FHVP). It represents the pressure difference between the portal vein and IVC.</p>\n<p class=\"p1\"><strong>Interpretation of HVPG values</strong>:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td>HVPG value</td>\n<td>Interpretation</td>\n</tr>\n<tr>\n<td>1-5 mmHg</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>&gt;5 mmHg&nbsp;</td>\n<td>Portal hypertension</td>\n</tr>\n<tr>\n<td>&ge;10 mmHg</td>\n<td>Clinically significant portal hypertension, varices can develop</td>\n</tr>\n<tr>\n<td>&ge;12 mmHg</td>\n<td>Risk of variceal bleeding and ascites</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p class=\"p1\">&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1222",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a posthepatic cause of portal hypertension?",
      "choices": [
        {
          "id": 1,
          "text": "Budd-Chiari syndrome"
        },
        {
          "id": 2,
          "text": "Schistosomiasis"
        },
        {
          "id": 3,
          "text": "Portal vein thrombosis"
        },
        {
          "id": 4,
          "text": "Banti's syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Budd-Chiari syndrome</strong> is a <strong>posthepatic</strong> cause of portal hypertension.</p>\n<p>Budd Chiari syndrome&nbsp;is a congestive hepatopathy characterized by the&nbsp;<strong>obstruction of</strong> <strong>hepatic venous outflow</strong>. The most common cause is due to hepatic vein thrombosis. Obstruction of two or more major hepatic veins causes Budd-Chiari syndrome. It is characterized by <strong>hepatomegaly</strong>, <strong>ascites</strong>, and <strong>abdominal pain</strong>.</p><hr><h3>Related Pearl: Causes of Portal Hypertension</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ba11a261470c410298f73941ff987a2fx1280x2190.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1224",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs is used to reduce the intrahepatic resistance in portal hypertension?",
      "choices": [
        {
          "id": 1,
          "text": "Propranolol"
        },
        {
          "id": 2,
          "text": "Carvedilol"
        },
        {
          "id": 3,
          "text": "Octreotide"
        },
        {
          "id": 4,
          "text": "Terlipressin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Carvedilol</strong> is used to <strong>reduce</strong> the <strong>intrahepatic resistance</strong> in portal hypertension.</p>\n<p>The pharmacologic <strong>management of portal hypertension</strong> includes:</p>\n<ul>\n<li>Drugs that <strong>reduce</strong> the <strong>portal blood flow</strong>\n<ul>\n<li>Non-selective&nbsp;&beta; blockers - Propranolol and nadolol are preferred</li>\n<li>Somatostatin and its analogs - Octreotide, lanreotide, and vapreotide</li>\n<li>Vasopressin and analogs - Terlipressin</li>\n</ul>\n</li>\n<li>Drugs that <strong>decrease</strong> the <strong>intrahepatic resistance&nbsp;</strong>\n<ul>\n<li>Carvedilol - due to its&nbsp;&alpha; blockade property</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1223",
      "difficulty": "hard"
    },
    {
      "text": "Ascitic tap done on a patient with abdominal distention revealed a SAAG of 1.4g/dL. What is the likely cause of his ascites?",
      "choices": [
        {
          "id": 1,
          "text": "Portal hypertension"
        },
        {
          "id": 2,
          "text": "Nephrotic syndrome"
        },
        {
          "id": 3,
          "text": "Peritoneal tuberculosis"
        },
        {
          "id": 4,
          "text": "Biliary leak"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The serum ascites albumin gradient of<strong>&nbsp;&ge;1.1g/dL </strong>is suggestive of <strong>portal hypertension.</strong></p>\n<p>SAAG helps distinguish ascites caused by portal hypertension from other causes of ascites.</p><hr><h3>Related Pearl: Serum Ascites Albumin Gradient  (SAAG)</h3><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1230",
      "difficulty": "easy"
    },
    {
      "text": "A patient presented with massive abdominal swelling. Paracentesis fluid was sent for lab analysis and results show serum protein to be 3g/dL and ascitic fluid protein to be 1g/dL. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Congestive heart failure"
        },
        {
          "id": 2,
          "text": "Early Budd Chiari syndrome"
        },
        {
          "id": 3,
          "text": "Late Budd Chiari syndrome"
        },
        {
          "id": 4,
          "text": "Tuberculosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The likely diagnosis in the given clinical scenario with <strong>serum-ascites albumin gradient (SAAG)</strong> <strong>&gt;1.1g/dL</strong> [calculated as serum albumin level - ascitic fluid albumin level, which in this case is 3-1=2g/dL] and <strong>ascitic fluid protein &lt;2.5 g/dL</strong> is<strong> late Budd Chiari syndrome.</strong></p>\n<p>Serum-ascites albumin gradient (SAAG) can be used to differentiate between ascites due to <strong>portal hypertension</strong> and <strong>non-portal hypertensive ascites.</strong> It represents the pressure within the hepatic sinusoids and correlates with the <strong>hepatic venous pressure gradient.</strong></p>\n<p>It is given by the formula:&nbsp;SAAG = Serum albumin level - Ascitic fluid albumin level</p>\n<p>Interpretation of SAAG:</p>\n<ul>\n<li aria-level=\"1\">SAAG <strong>&ge;1.1</strong> g/dL indicates that the ascites is due to increased pressure in the hepatic sinusoids. It reflects the presence of<strong> portal hypertension.</strong></li>\n<li aria-level=\"1\">SAAG <strong>&lt;1.1</strong> g/dL indicates that the ascites is not related to portal hypertension. It may be due to i<strong>nfection or malignancy.</strong></li>\n</ul>\n<p>In cases with high-SAAG (&ge;1.1), <strong>ascitic protein level analysis</strong> further helps in identifying the etiology:</p>\n<ul>\n<li aria-level=\"1\"><strong>&ge;2.5 g/dL</strong> indicates that the hepatic sinusoids are normal and are allowing the passage of protein into the ascites as in <strong>early Budd-Chiari syndrome.</strong></li>\n<li aria-level=\"1\"><strong>&lt;2.5 g/dL</strong> indicates that the hepatic sinusoids have been damaged and scarred and no longer allow passage of protein as in <strong>late Budd-Chiari syndrome</strong></li>\n</ul><hr><h3>Related Pearl: Serum Ascites Albumin Gradient  (SAAG)</h3><p>The serum ascites albumin gradient is calculated as follows:</p>\n<p>SAAG = Serum albumin - Ascitic fluid albumin</p>\n<p>It can be used to determine the cause of ascites following ascitic fluid analysis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08ad7499e5e74b398f3c98a430c6af02x1200x1361.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6821",
      "difficulty": "medium"
    },
    {
      "text": "A patient is said to have refractory ascites if the ascites does not resolve even after:<div class='question-desc-html'><ol>\n<li>Dietary sodium restriction</li>\n<li>100mg / day spironolactone&nbsp;</li>\n<li>160mg / day furosemide</li>\n<li>100mg / day furosemide</li>\n<li>400mg / day spironolactone</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 4"
        },
        {
          "id": 2,
          "text": "4 and 5"
        },
        {
          "id": 3,
          "text": "1, 3 and 5"
        },
        {
          "id": 4,
          "text": "2 and 3"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Refractory ascites</strong> is defined as the inability to mobilize ascitic fluid despite:</p>\n<ul>\n<li>Compliance with dietary <strong>sodium restriction</strong></li>\n<li>Administration of maximum doses of diuretics -\n<ul>\n<li><strong>400mg </strong>of <strong>spironolactone</strong> per day<strong>&nbsp;</strong>and</li>\n<li><strong>160mg </strong>of <strong>furosemide</strong> per day</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1334",
      "difficulty": "medium"
    },
    {
      "text": "What is the minimum absolute neutrophilic count that should be present in the ascitic fluid to diagnose a patient with spontaneous bacterial peritonitis?",
      "choices": [
        {
          "id": 1,
          "text": ">250/µL"
        },
        {
          "id": 2,
          "text": ">150/µL"
        },
        {
          "id": 3,
          "text": ">300/µL"
        },
        {
          "id": 4,
          "text": ">200/µL"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The diagnosis of <strong>spontaneous bacterial peritonitis</strong>(SBP) is made when the fluid sample has an <strong>absolute neutrophil count &gt;250/&mu;L.</strong></p>\n<p>SBP is the&nbsp;spontaneous infection of the ascitic fluid without an intraabdominal source.&nbsp;Infection with<strong><em> E.coli</em></strong> and other gut bacteria is most <strong>commonly seen</strong>. However, gram-positive bacteria like <em>Streptococcus viridans</em>, <em>Staphylococcus</em> <em>aureus</em>, and <em>Enterococcus</em> sp., can also be found.&nbsp;<strong>Abdominal paracentesis</strong>&nbsp;is the investigation of choice. It can be managed with <strong>antibiotic</strong> therapy.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1231",
      "difficulty": "easy"
    },
    {
      "text": "A cirrhotic patient admitted for ascites complained of abdominal pain on the 2nd day of his hospital stay. On examination, he was febrile. His lab reports are given below. Which of the following is false about his condition?<div class='question-desc-html'><p>Total WBC count- 12 400×10<sup>6</sup>/litre</p>\n<p>C reactive protein- 4.3 mg/dl</p>\n<p>Serology- positive for HBs-antigen</p>\n<p>Absolute neutrophil count in ascitic fluid- 743 cells/μl</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "E.coli is the most commonly isolated organism"
        },
        {
          "id": 2,
          "text": "Prophylaxis against this condition is recommended in upper GI bleed"
        },
        {
          "id": 3,
          "text": "Third generation cephalosporins are used for treatment"
        },
        {
          "id": 4,
          "text": "Weekly antibiotic prophylaxis is recommended to prevent recurrence"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario along with <strong>ANC ≥ 250 cells/μl</strong> in ascitic fluid is suggestive of <strong>spontaneous bacterial peritonitis</strong> (SBP). <strong>Daily antibiotic prophylaxis</strong> is recommended in patients who have had an episode of SBP to <strong>prevent</strong> a <strong>recurrence</strong>. </p>\n<p>SBP is the spontaneous infection of the ascitic fluid without an intraabdominal source. The <strong>most common</strong> causative organisms are <em><strong>E.coli </strong></em>and other gut bacteria. The diagnosis of SBP is made when the ascitic fluid has an <strong>absolute neutrophil count &gt;250/μl.</strong></p>\n<p>According to the latest recommendations, weekly antibiotic prophylaxis is no longer recommended. For<span dir=\"ltr\" role=\"presentation\"> patients with low protein ascites (&lt;1.5 g/dL [15</span><span dir=\"ltr\" role=\"presentation\">g/L]) along with either impaired renal function or liver failure, we use prolonged outpatient </span><span dir=\"ltr\" role=\"presentation\">trimethoprim-sulfamethoxazole</span><span dir=\"ltr\" role=\"presentation\"> (one double-strength tablet daily). Alternatives include ciprofloxacin 500 mg per day or norfloxacin 400 mg per day.</span></p>\n<p><span dir=\"ltr\" role=\"presentation\"> For patients on chronic trimethoprim-sulfamethoxazole therapy, renal function should be monitored by checking serum electrolytes, blood urea nitrogen (BUN) and creatinine every one to six months depending on the stability of patient. If there is worsening renal function, trimethoprim-sulfamethoxazole should be discontinued.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1232",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following cannot be used to predict the risk of bleeding of oesophageal varices?",
      "choices": [
        {
          "id": 1,
          "text": "Severity of cirrhosis"
        },
        {
          "id": 2,
          "text": "Size of the varices"
        },
        {
          "id": 3,
          "text": "Location of the varices"
        },
        {
          "id": 4,
          "text": "Number of varices"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The risk of bleeding in a patient with oesophageal varices cannot be predicted based on the number of varices present.</p>\n<p>&nbsp;The factors that are used to&nbsp;<strong>predict</strong> the <strong>risk of variceal bleeding</strong> are:&nbsp;</p>\n<ul>\n<li><strong>Severity of cirrhosis</strong> (Child&rsquo;s class, MELD score)</li>\n<li>History of a <strong>previous variceal bleed</strong></li>\n<li><strong>Location</strong> of the varices - varices with a thinner layer of supporting tissue are likely to bleed more</li>\n<li><strong>Size</strong> of the varices - larger varices have a higher risk of bleeding</li>\n<li><strong>Endoscopic appearance </strong>of varices&nbsp;- Presence of red wale sign, hematocystic spots, diffuse erythema, and cherry red spots are associated with increased risk of bleeding</li>\n<li><strong>Variceal pressure</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1227",
      "difficulty": "medium"
    },
    {
      "text": "In a patient with which of the following conditions would you not recommend a transjugular intrahepatic portosystemic shunt?",
      "choices": [
        {
          "id": 1,
          "text": "Ectopic varices"
        },
        {
          "id": 2,
          "text": "Refractory ascites"
        },
        {
          "id": 3,
          "text": "Budd Chiari syndrome"
        },
        {
          "id": 4,
          "text": "Hepatic encephalopathy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Transjugular intrahepatic portosystemic shunt (<strong>TIPS</strong>) is not recommended in <strong>hepatic encephalopathy</strong> as it can <strong>aggravate</strong> its symptoms.</p>\n<p><strong>TIPS&nbsp;</strong>creates a <strong>low-resistance channel</strong> between the hepatic vein and an intrahepatic branch of the portal vein. It uses a <strong>percutaneous approach</strong> under <strong>angiographic guidance</strong>. This reduces portal pressure.&nbsp;</p>\n<p>It is used in the management of:</p>\n<ul>\n<li>Oesophageal varices - in patients who fail medical or endoscopic management and have a poor surgical outcome</li>\n<li><strong>Refractory ascites</strong></li>\n<li>Gastric varices</li>\n<li><strong>Ectopic varices</strong></li>\n<li>Portal hypertensive gastropathy</li>\n<li>Hepatorenal syndrome</li>\n<li><strong>Budd Chiari syndrome</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/564defbe79384fd299c2ca53488b2b4cx600x1199.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1229",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man with hematemesis is rushed to the casualty. On examination, he is icteric, PR-122 /min and BP- 88/64 mmHg. The following finding is seen on his abdomen. Which of the following is false regarding his initial management?",
      "choices": [
        {
          "id": 1,
          "text": "pRBC is used to maintain Hb between 7-9g/dL"
        },
        {
          "id": 2,
          "text": "Prophylactic antibiotics given before endoscopy"
        },
        {
          "id": 3,
          "text": "IV octreotide is used to acheive hemostasis"
        },
        {
          "id": 4,
          "text": "Upper GI endoscopy is only performed after 12 hours"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario along with the image showing&nbsp;<strong>caput-medusae</strong> is suggestive of acute <strong>esophageal variceal bleeding</strong> due to portal hypertension<strong>. Upper GI endoscopy</strong> is performed <strong>within 12 hours</strong> after fluid resuscitation in variceal bleeding.&nbsp;</p>\n<p>The <strong>management of esophageal variceal bleeding</strong> involves:</p>\n<ul>\n<li><strong>Resuscitation</strong> with IV fluids, airway protection, and oxygen</li>\n<li>Blood transfusion&nbsp;to maintain <strong>Hb </strong>between<strong> 7-9g/dL</strong></li>\n<li>Antibiotic prophylaxis with <strong>ceftriaxone </strong>before endoscopy</li>\n<li>An attempt at hemostasis with <strong>octreotide</strong> or <strong>terlipressin</strong> or <strong>vasopressin</strong></li>\n<li>Upper GI endoscopy within 12 hours after fluid resuscitation to confirm the source of the bleed</li>\n<li><strong>Endoscopic variceal ligation</strong> of sclerotherapy</li>\n<li>In case, of failure or rebleeding - <strong>TIPS</strong></li>\n</ul>\n<p><strong>Nonselective beta-blockers</strong> like propranolol and nadolol are used in the <strong>prophylaxis</strong> of variceal bleeding.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/843bb40225884e0b847c52871b9948cfx1200x1551.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d06079aeadcc4fbcbceee016f0dfbfb6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1381",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false about the given image?",
      "choices": [
        {
          "id": 1,
          "text": "Esophageal balloon should be deflated for about 5 mins every 6 hours"
        },
        {
          "id": 2,
          "text": "Gastric balloon should be inflated first"
        },
        {
          "id": 3,
          "text": "Pressure in the oesophageal balloon should not exceed  60 mm Hg."
        },
        {
          "id": 4,
          "text": "Endotracheal intubation prior to tube insertion reduces the risk of pulmonary aspiration"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image shows <strong>Sengstaken-Blakemore tube</strong>. Pressure in the <strong>oesophageal balloon</strong> should not exceed <strong>45 mm Hg</strong>.</p>\n<p>It is used for balloon tamponade in <strong>variceal hemorrhage</strong> when medical therapy fails or is not available.&nbsp;Initially, only the <strong>gastric balloon</strong> should be inflated, with <strong>200&ndash; 250 mL of air</strong>, as this will usually control bleeding.&nbsp;The <strong>oesophageal balloon</strong> is used in continued bleeding, it should be <strong>deflated</strong> for about 5 minutes every 6&nbsp;hours to <strong>avoid oesophageal mucosal damage.</strong></p>\n<p>Endotracheal <strong>intubation</strong> prior to tube insertion <strong>reduces</strong> the risk of <strong>pulmonary aspiration</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a9cf7ed3c29401c93358df67f1872a7x1280x1825.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/08faaae1be1a46a7a9ce4f762e69edb5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1397",
      "difficulty": "hard"
    },
    {
      "text": "A patient with hereditary hemochromatosis shows marked confusion and gross disorientation. He is drowsy but responds to pain and voice stimuli. What is the most likely grading of hepatic encephalopathy in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Grade 1"
        },
        {
          "id": 2,
          "text": "Grade 2"
        },
        {
          "id": 3,
          "text": "Grade 3"
        },
        {
          "id": 4,
          "text": "Grade 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Gross <strong>disorientation&nbsp;</strong>with an <strong>intact&nbsp;response</strong> to <strong>pain</strong> and <strong>voice</strong> suggest&nbsp;<strong>grade 3 </strong>hepatic encephalopathy.</p>\n<p><strong>Hepatic encephalopathy</strong> is the alteration of mental status and cognitive function occurring in liver failure. This occurs due to the<strong> failure of removal</strong> of gut-derived neurotoxins like <strong>ammonia by liver.</strong> These neurotoxins enter the brain leading to the development of symptoms.</p><hr><h3>Related Pearl: Grading of hepatic encephalopathy - West Haven Criteria</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Clinical grade</strong></td>\n<td><strong>Clinical signs</strong></td>\n<td><strong>Category</strong></td>\n</tr>\n<tr>\n<td><strong>Minimal&nbsp;</strong></td>\n<td>\n<p>Abnormal psychometric or neurophysiological tests</p>\n<p>No clinical manifestations</p>\n</td>\n<td>\n<p>Covert HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 1</strong></td>\n<td>\n<p>Altered sleep pattern</p>\n<p>Changes in behavior</p>\n<p>Slurred speech</p>\n<p>Mild confusion</p>\n</td>\n<td>\n<p>Covert HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 2</strong></td>\n<td>\n<p>Disoriented</p>\n<p>Lethargic</p>\n<p>Inappropriate behavior</p>\n<p>Asterixis</p>\n</td>\n<td>\n<p>&nbsp;Overt HE</p>\n</td>\n</tr>\n<tr>\n<td><strong>Grade 3</strong></td>\n<td>\n<p>Stuporous</p>\n<p>Responds to pain and voice</p>\n<p>Gross disorientation</p>\n</td>\n<td>Overt HE</td>\n</tr>\n<tr>\n<td><strong>Grade 4</strong>&nbsp;</td>\n<td>\n<p>Unresponsive to voice or pain</p>\n<p>Comatose</p>\n</td>\n<td>\n<p>Overt HE</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1061",
      "difficulty": "medium"
    },
    {
      "text": "What is the earliest symptom of hepatic encephalopathy?",
      "choices": [
        {
          "id": 1,
          "text": "Mood changes"
        },
        {
          "id": 2,
          "text": "Asterixis"
        },
        {
          "id": 3,
          "text": "Altered sleep pattern"
        },
        {
          "id": 4,
          "text": "Disorientation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>earliest symptom</strong> of hepatic encephalopathy is an<strong> alteration in sleep pattern</strong>.</p>\n<p>Other<strong> signs and symptoms</strong> of <strong>hepatic encephalopathy</strong> include:&nbsp;</p>\n<ul>\n<li>Asterixis also called the flapping tremor</li>\n<li>Mood changes and inappropriate behavior</li>\n<li>Disorientation and confusion</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1240",
      "difficulty": "easy"
    },
    {
      "text": "A cirrhotic patient was admitted following variceal bleeding. On the 3rd day of his hospital stay, he appears to be drowsy and confused. His wife reports that he had been awake throughout the previous night. On examination, flapping tremors were noticed. Which of the following is least likely to have precipitated his symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Antibiotics"
        },
        {
          "id": 2,
          "text": "Peritoneal tap"
        },
        {
          "id": 3,
          "text": "Diuretics"
        },
        {
          "id": 4,
          "text": "Urinary tract infection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of<strong> hepatic encephalopathy</strong>. Antibiotics are unlikely to precipitate hepatic encephalopathy.</p>\n<p>The common <strong>precipitating factors</strong> of hepatic encephalopathy are :</p>\n<ul>\n<li>Gastrointestinal bleeding</li>\n<li>Infections like SBP or <strong>UTIs</strong></li>\n<li><strong>Peritoneal tap</strong></li>\n<li>Constipation</li>\n<li>Renal failure</li>\n<li>Hypovolemia</li>\n<li>Hypoxia</li>\n<li>Drugs - sedatives, antidepressants, <strong>diuretics</strong></li>\n<li>Hypoglycemia</li>\n<li>Hypokalemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1242",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following antibiotics could be used in the treatment of patients with hepatic encephalopathy?",
      "choices": [
        {
          "id": 1,
          "text": "Rifaximin"
        },
        {
          "id": 2,
          "text": "Azithromycin"
        },
        {
          "id": 3,
          "text": "Doxycycline"
        },
        {
          "id": 4,
          "text": "Rifampicin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Rifaximin</strong> can be used in the treatment of hepatic encephalopathy. It <strong>lowers</strong> blood <strong>ammonia levels</strong>.&nbsp;</p>\n<p><strong>Treatment of hepatic encephalopathy</strong> includes:</p>\n<ul>\n<li>Correction of precipitating factors</li>\n<li>Lactulose - decreased GI transit time due to cathartic actions leading to increased elimination of ammonia</li>\n<li>Rifaximin - lowers the blood ammonia levels</li>\n<li>L-ornithine L-aspartate - stimulate the urea cycle, with resulting loss of ammonia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1245",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not part of the diagnostic criteria of hepatorenal syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "50% increase in creatinine from baseline within 7 days"
        },
        {
          "id": 2,
          "text": "Rise in creatinine of 0.3 mg/dl in 48 hours"
        },
        {
          "id": 3,
          "text": "Presence of shock"
        },
        {
          "id": 4,
          "text": "No recent use of nephrotoxic agent"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>absence of shock</strong> is a part of the diagnostic criteria for <strong>hepatorenal syndrome</strong>.</p>\n<p>Hepatorenal syndrome is a progressive <strong>renal failure in</strong> patients with acute or chronic <strong>liver disease</strong>.&nbsp;</p>\n<p>The<strong> diagnostic criteria</strong> for hepatorenal syndrome include:</p>\n<ul>\n<li>Cirrhosis with ascites</li>\n<li>Diagnosis of acute kidney injury (AKI)\n<ul>\n<li>Increase in serum creatinine of&nbsp;&ge; 0.3mg/dL in 48 hours, OR</li>\n<li>50% increase in serum creatinine from baseline within 7 days</li>\n</ul>\n</li>\n<li>Absence of shock</li>\n<li>No evidence of recent use of nephrotoxic agents</li>\n<li>Absence of intrinsic renal disease</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1384",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following clinical features is most likely to be seen in patients with hepatopulmonary syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Trepopnea"
        },
        {
          "id": 2,
          "text": "Nocturnal dyspnea"
        },
        {
          "id": 3,
          "text": "Orthopnea"
        },
        {
          "id": 4,
          "text": "Platypnea"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the given options, <strong>platypnea</strong> is most likely to be seen in patients with <strong>hepatopulmonary syndrome</strong>.</p>\n<p>Hepatopulmonary syndrome is characterized by a triad of <strong>liver disease</strong>, <strong>hypoxemia</strong>, and <strong>intrapulmonary vascular dilatations</strong>. Most patients have dyspnea on exertion. The classic clinical manifestations are:</p>\n<ul>\n<li><strong>Platypnea</strong> - Increase in dyspnea when the patient moves from supine to upright position</li>\n<li><strong>Orthodeoxia</strong> - Decrease in arterial oxygen tension when the patient moves from supine to upright position</li>\n</ul>\n<p>The hypoxemia is due to a <strong>ventilation-perfusion mismatch</strong> which causes an increased alveolar-arterial (A-a) gradient. The most sensitive test for diagnosis is <strong>contrast bubble echocardiography.</strong> </p>\n<p><strong>Liver transplantation </strong>is the <strong>definitive treatment</strong> of this condition following which the symptoms subside.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1390",
      "difficulty": "medium"
    },
    {
      "text": "A 52-year-old man presents with oliguria, abdominal distension, and pedal edema.  His medical records show long-standing cirrhosis with multiple hospitalisations for ascites and hepatic encephalopathy. His lab reports are given below. What is the best treatment for his condition?<div class='question-desc-html'><p>AST- 148 U/L</p>\n<p>ALT- 64 U/L</p>\n<p>Total bilirubin- 8.9 mg/dL</p>\n<p>Sr. Creatinine- 7.6 mg/dL</p>\n<p>Blood urea nitrogen- 84 mg/dL</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Midodrine"
        },
        {
          "id": 2,
          "text": "Liver transplant"
        },
        {
          "id": 3,
          "text": "Intravenous albumin"
        },
        {
          "id": 4,
          "text": "TIPS"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>hepatorenal syndrome</strong>. The best treatment modality for it is <strong>liver transplantation</strong>.</p>\n<p>Hepatorenal syndrome is characterised by a rise in:</p>\n<ul>\n<li>AST</li>\n<li>ALT</li>\n<li>Total bilirubin</li>\n<li>Serum creatinine</li>\n<li>Blood urea nitrogen (BUN).</li>\n</ul>\n<p><strong>Management of hepatorenal syndrome</strong> include:</p>\n<ul>\n<li>Norepinephrine</li>\n<li>Octreotide</li>\n<li>Terlipressin</li>\n<li><strong>Midodrine</strong></li>\n<li>Intravenous <strong>albumin</strong>&nbsp;</li>\n<li>Liver transplantation- definitive treatment</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1388",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following conditions is not a MELD exception?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatopulmonary syndrome"
        },
        {
          "id": 2,
          "text": "Portopulmonary hypertension"
        },
        {
          "id": 3,
          "text": "Primary hyperoxaluria"
        },
        {
          "id": 4,
          "text": "Chronic Hepatitis B"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Chronic Hepatitis B is not a MELD exception.</p>\n<p><strong>MELD </strong>(Model for End-stage Liver Disease)&nbsp;<strong>score</strong> is used to <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong>. However, there are <strong>certain diseases</strong> that impair patient survival and are <strong>not accounted for in</strong> the <strong>MELD score</strong>. Patients with these diseases are <strong>given upgraded MELD points</strong> to accurately represent the mortality risk and these conditions are <strong>called MELD exceptions</strong>.&nbsp;</p>\n<p>The MELD exceptions include:-</p>\n<ul>\n<li><strong>Portopulmonary hypertension</strong></li>\n<li>Hepatocellular carcinoma</li>\n<li>Familial amyloid polyneuropathy</li>\n<li><strong>Primary hyperoxaluria</strong> (necessitating liver-kidney transplantation)</li>\n<li>Cystic fibrosis with liver disease</li>\n<li>Highly selected cases of hilar cholangiocarcinoma.</li>\n<li><strong>Hepatopulmonary syndrome</strong></li>\n<li>Hepatic artery thrombosis 7&ndash;14 days post-liver transplantation.</li>\n</ul><hr><h3>Related Pearl: Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0</h3><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\"bulletIndent1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9603",
      "difficulty": "hard"
    },
    {
      "text": "Which among the following is false?",
      "choices": [
        {
          "id": 1,
          "text": "Components of MELD (Model for end stage liver disease) scoring system are creatinine, bilirubin, International normalized ratio (INR), serum sodium (mEq/L)."
        },
        {
          "id": 2,
          "text": "Components of CTP(Child Turcotte Pugh) score are albumin, bilirubin, INR, ascites, encephalopathy"
        },
        {
          "id": 3,
          "text": "Components of CTP (Child Turcotte Pugh ) are creatinine, bilirubin, International normalized ratio (INR)"
        },
        {
          "id": 4,
          "text": "MELD score is used to assess and prioritize patients awaiting liver transplantation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>Child Turcotte Pugh</strong> (CTP) score <strong>does not</strong> include <strong>creatinine</strong>.</p>\n<p>The <strong>components of&nbsp;</strong>the<strong> CTP score </strong>are:</p>\n<ul>\n<li>Albumin</li>\n<li>Bilirubin</li>\n<li>International normalized ratio (INR)</li>\n<li>Ascites</li>\n<li>Encephalopathy</li>\n</ul>\n<p>The <strong>Model for End-stage liver disease</strong>&nbsp;(MELD 3.0) is used to&nbsp;<strong>prioritize patients awaiting liver transplantation&nbsp;</strong>and&nbsp;includes:</p>\n<ul>\n<li><strong>Female sex</strong></li>\n<li>Bilirubin</li>\n<li><strong>Albumin</strong></li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul><hr><h3>Related Pearl: Child-Turcotte-Pugh Score</h3><p>The Child&ndash;Turcotte&ndash;Pugh (CTP) score was originally developed to <strong>evaluate the risk of portocaval shunt procedures </strong>performed for<strong> portal hypertension.</strong>&nbsp;It is also useful in predicting the surgical risks of other intra-abdominal operations performed in cirrhotic patients.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Variable</strong></p>\n</td>\n<td>\n<p><strong>1 Point</strong></p>\n</td>\n<td>\n<p><strong>2 Points</strong></p>\n</td>\n<td>\n<p><strong>3 Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bilirubin level</p>\n</td>\n<td>\n<p>&lt;2 mg/dL</p>\n</td>\n<td>\n<p>2&ndash;3 mg/dL</p>\n</td>\n<td>\n<p>&gt;3 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albumin level</p>\n</td>\n<td>\n<p>&gt;3.5 g/dL</p>\n</td>\n<td>\n<p>2.8&ndash;3.5 g/dL</p>\n</td>\n<td>\n<p>&lt;2.8 g/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin time (increased seconds)</p>\n<p>International normalized ratio</p>\n</td>\n<td>\n<p>1&ndash;3</p>\n<p>&lt;1.7</p>\n</td>\n<td>\n<p>4&ndash;6</p>\n<p>1.7&ndash;2.3</p>\n</td>\n<td>\n<p>&gt;6</p>\n<p>&gt;2.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Encephalopathy</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascites</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Child-Turcotte-Pugh class and overall surgical mortality rates:</strong></p>\n<ul>\n<li>Class A = 5&ndash;6 points - Well-compensated - 10% mortality</li>\n<li>Class B = 7&ndash;9 points - Decompensated and significant&nbsp; functional compromise - 30% mortality</li>\n<li>Class C = 10&ndash;15 points - Severerly decompensated - 75-80% mortality</li>\n</ul>\n<p><strong>Prognosis of the various CTP classes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>1-year survival rate &nbsp;%</strong></td>\n<td><strong>2-year survival rate %</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>100</td>\n<td>85</td>\n</tr>\n<tr>\n<td>B</td>\n<td>80</td>\n<td>60</td>\n</tr>\n<tr>\n<td>C</td>\n<td>45</td>\n<td>35</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Revised Model for End-stage liver disease  (MELD) scoring system: MELD 3.0</h3><p>MELD 3.0 score has the following components (Mnemonic <strong>F BASIC</strong>)</p>\n<ul>\n<li>Female sex</li>\n<li>Bilirubin</li>\n<li>Albumin</li>\n<li>Serum sodium (mEq/L)</li>\n<li>INR (International Normalized ratio)</li>\n<li>Creatinine</li>\n</ul>\n<p><strong>Uses:</strong></p>\n<ul>\n<li>Predict short-term prognosis in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) insertion</li>\n<li>Assess and <strong>prioritize patients</strong> awaiting <strong>liver transplantation</strong></li>\n<li>Assess prognosis in cirrhosis</li>\n</ul>\n<p class=\"bulletIndent1\">&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7510",
      "difficulty": "medium"
    },
    {
      "text": "What is the Child-Turcotte-Pugh class for the patient who has a serum bilirubin 2.5 mg/dl, serum albumin 3 g/dl, prothrombin time increased by 5 seconds (INR = 2), no encephalopathy, and mild ascites?",
      "choices": [
        {
          "id": 1,
          "text": "Class A"
        },
        {
          "id": 2,
          "text": "Class B"
        },
        {
          "id": 3,
          "text": "Class C"
        },
        {
          "id": 4,
          "text": "Class D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given patient belongs to Child-Turcotte-Pugh <strong>class B</strong>.</p>\n<p>The score can be calculated as follows:</p>\n<div>Serum bilirubin-2.5mg/dl: 2&nbsp;</div>\n<div>Serum albumin-3g/dl: 2</div>\n<div>Prothrombin time-5 seconds or INR-2: 2</div>\n<div>No encephalopathy: 1</div>\n<div>Mild ascites: 2</div>\n<p>Therefore, the <strong>Child-Turcotte-Pugh score</strong> is (2+2+2+1+2)= <strong>9</strong> which is included in Class B.</p><hr><h3>Related Pearl: Child-Turcotte-Pugh Score</h3><p>The Child&ndash;Turcotte&ndash;Pugh (CTP) score was originally developed to <strong>evaluate the risk of portocaval shunt procedures </strong>performed for<strong> portal hypertension.</strong>&nbsp;It is also useful in predicting the surgical risks of other intra-abdominal operations performed in cirrhotic patients.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Variable</strong></p>\n</td>\n<td>\n<p><strong>1 Point</strong></p>\n</td>\n<td>\n<p><strong>2 Points</strong></p>\n</td>\n<td>\n<p><strong>3 Points</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bilirubin level</p>\n</td>\n<td>\n<p>&lt;2 mg/dL</p>\n</td>\n<td>\n<p>2&ndash;3 mg/dL</p>\n</td>\n<td>\n<p>&gt;3 mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albumin level</p>\n</td>\n<td>\n<p>&gt;3.5 g/dL</p>\n</td>\n<td>\n<p>2.8&ndash;3.5 g/dL</p>\n</td>\n<td>\n<p>&lt;2.8 g/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Prothrombin time (increased seconds)</p>\n<p>International normalized ratio</p>\n</td>\n<td>\n<p>1&ndash;3</p>\n<p>&lt;1.7</p>\n</td>\n<td>\n<p>4&ndash;6</p>\n<p>1.7&ndash;2.3</p>\n</td>\n<td>\n<p>&gt;6</p>\n<p>&gt;2.3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Encephalopathy</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascites</p>\n</td>\n<td>\n<p>None</p>\n</td>\n<td>\n<p>Controlled</p>\n</td>\n<td>\n<p>Uncontrolled</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Child-Turcotte-Pugh class and overall surgical mortality rates:</strong></p>\n<ul>\n<li>Class A = 5&ndash;6 points - Well-compensated - 10% mortality</li>\n<li>Class B = 7&ndash;9 points - Decompensated and significant&nbsp; functional compromise - 30% mortality</li>\n<li>Class C = 10&ndash;15 points - Severerly decompensated - 75-80% mortality</li>\n</ul>\n<p><strong>Prognosis of the various CTP classes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>1-year survival rate &nbsp;%</strong></td>\n<td><strong>2-year survival rate %</strong></td>\n</tr>\n<tr>\n<td>A</td>\n<td>100</td>\n<td>85</td>\n</tr>\n<tr>\n<td>B</td>\n<td>80</td>\n<td>60</td>\n</tr>\n<tr>\n<td>C</td>\n<td>45</td>\n<td>35</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3073",
      "difficulty": "medium"
    }
  ]
}